Kelyniam Global, Inc. (KLYG)

OTCMKTS · Delayed Price · Currency is USD

0.0911

-0.0289 (-24.08%)

Mar 6, 2026, 4:00 PM EST

-62.48% (1Y)

Market Cap	5.76M
Revenue (ttm)	2.67M
Net Income (ttm)	-218.47K
Shares Out	49.89M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	800
Average Volume	15,534
Open	0.0911
Previous Close	0.1200
Day's Range	0.0911 - 0.0911
52-Week Range	0.0530 - 0.3000
Beta	0.53
RSI	48.46
Earnings Date	Mar 18, 2026

About Kelyniam Global

Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States. The company is also involved in the development, manufacture, and distribution of custom cranial implant for patients requiring the reconstruction of cranial and facial structures. It serves surgeons, health systems, and payors. The company was formerly known as Ketner Global Investments, Inc. and ... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2005

Employees 20

Stock Exchange OTCMKTS

Ticker Symbol KLYG

Full Company Profile

Financial Performance

In 2023, Kelyniam Global's revenue was $2.67 million, a decrease of -11.44% compared to the previous year's $3.02 million. Losses were -$218,471, 123.9% more than in 2022.

Financial Statements

News

There is no news available yet.